134 related articles for article (PubMed ID: 3612693)
21. Synthesis and antidiuretic activities of novel glycoconjugates of arginine-vasopressin.
Susaki H; Suzuki K; Ikeda M; Yamada H; Watanabe HK
Chem Pharm Bull (Tokyo); 1998 Oct; 46(10):1530-7. PubMed ID: 9810690
[TBL] [Abstract][Full Text] [Related]
22. Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule.
Kowalczyk W; Prahl A; Derdowska I; Sobolewski D; Olejnik J; Zabrocki J; Borovicková L; Slaninová J; Lammek B
J Med Chem; 2006 Mar; 49(6):2016-21. PubMed ID: 16539389
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
[TBL] [Abstract][Full Text] [Related]
24. Design of potent antagonists of the vasopressor response to arginine-vasopressin.
Bankowski K; Manning M; Haldar J; Sawyer WH
J Med Chem; 1978 Sep; 21(9):850-3. PubMed ID: 722751
[TBL] [Abstract][Full Text] [Related]
25. Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin.
Manning M; Lammek B; Kolodziejczyk AM; Seto J; Sawyer WH
J Med Chem; 1981 Jun; 24(6):701-6. PubMed ID: 7252979
[TBL] [Abstract][Full Text] [Related]
26. Effects of vasopressin on the human non-pregnant uterus: studies with analogues of different vasopressor potencies.
Melin P; Trojnar J; Carlsson AM; Bengtsson B; Akerlund M; Robinson I
Eur J Pharmacol; 1988 Mar; 148(1):93-9. PubMed ID: 3383999
[TBL] [Abstract][Full Text] [Related]
27. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
Manning M; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
[TBL] [Abstract][Full Text] [Related]
29. N-Acetyl-[2-(O-methyl)tyrosine]arginine-vasopressin, an interesting antagonist of the vasopressor response to vasopressin.
Jones DA; Sawyer WH
J Med Chem; 1980 Jun; 23(6):696-8. PubMed ID: 7392038
[TBL] [Abstract][Full Text] [Related]
30. The influence of 1-aminocyclopentane-1-carboxylic acid at position 2 or 3 of AVP and its analogues on their pharmacological properties.
Kowalczyk W; Prahl A; Dawidowska O; Derdowska I; Sobolewski D; Hartrodt B; Neubert K; Slaninová J; Lammek B
J Pept Sci; 2005 Sep; 11(9):584-8. PubMed ID: 15747318
[TBL] [Abstract][Full Text] [Related]
31. Antidiuretic response in conscious dogs following peroral administration of arginine vasopressin and its analogues.
Vilhardt H; Bie P
Eur J Pharmacol; 1983 Sep; 93(3-4):201-4. PubMed ID: 6641789
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of three NH2-terminally extended arginine-vasopressins with prolonged biological activities.
Lammek B; Rekowski P; Kupryszewski G; Melin P; Ragnarsson U
Experientia; 1987 Dec; 43(11-12):1211-2. PubMed ID: 3691740
[TBL] [Abstract][Full Text] [Related]
33. The effects of N-terminal part modification of arginine vasopressin analogues with 2-aminoindane-2-carboxylic acid: a highly potent V2 agonist.
Kowalczyk W; Sobolewski D; Prahl A; Derdowska I; Borovicková L; Slaninová J; Lammek B
J Med Chem; 2007 Jun; 50(12):2926-9. PubMed ID: 17500550
[TBL] [Abstract][Full Text] [Related]
34. Influence of enantiomers of 1-naphthylalanine in position 2 of VAVP and dVAVP on their pharmacological properties.
Derdowska I; Prahl A; Kowalczyk W; Janecki M; Melhem S; Trzeciak HI; Lammek B
Eur J Med Chem; 2005 Jan; 40(1):63-8. PubMed ID: 15642410
[TBL] [Abstract][Full Text] [Related]
35. An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids.
Stoev S; Cheng LL; Olma A; Klis WA; Manning M; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1999 Mar; 5(3):141-53. PubMed ID: 10323558
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and some pharmacologic properties of five novel V1 or V1/V2 antagonists of AVP.
Lammek B; Wang YX; Derdowska I; Franco R; Gavras H
Peptides; 1989; 10(5):1109-12. PubMed ID: 2608555
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and structure-activity relationship of new arginine vasopressin analogues containing proline derivatives in position 2.
Kwiatkowska A; Lewandowska M; Borovičková L; Slaninová J; Lammek B; Prahl A
Chem Biol Drug Des; 2013 Mar; 81(3):420-8. PubMed ID: 23205571
[TBL] [Abstract][Full Text] [Related]
38. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors.
Manning M; Misicka A; Olma A; Klis WA; Bankowski K; Nawrocka E; Kruszynski M; Kolodziejczyk A; Cheng LL; Seto J
J Med Chem; 1987 Dec; 30(12):2245-52. PubMed ID: 2960812
[TBL] [Abstract][Full Text] [Related]
39. The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture.
Beck TR; Hassid A; Dunn MJ
J Pharmacol Exp Ther; 1980 Oct; 215(1):15-9. PubMed ID: 7452479
[TBL] [Abstract][Full Text] [Related]
40. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
